Bicara Therapeutics
BCAX
#7214
Rank
A$0.84 B
Marketcap
A$12.75
Share price
-7.46%
Change (1 day)
-54.35%
Change (1 year)

EPS for Bicara Therapeutics (BCAX)

EPS in 2026 (TTM): A-$4.56

According to Bicara Therapeutics's latest financial reports the company's current EPS (TTM) is A-$4.68. In 2025 the company made an earnings per share (EPS) of A-$3.82 an increase over its 2024 EPS that were of A-$3.87.

EPS history for Bicara Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.5619.27%
2025A-$3.82-1.21%
2024A-$3.87